OHR Pharmaceutical Company
OHR Pharmaceutical develops products for the treatment of cancer cachexia and wet age-related macular degeneration.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2009
Employees Number:
1-10
Funding Status:
IPO
Investors Number:
1
Total Funding:
$3M
Estimated Revenue:
Less than $1M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership